Technetium-99m gamma emission (99mTc gamma emission)

Gamma photon emission from technetium-99m" refers to the nuclear decay process of the metastable isotope technetium-99m (99mTc), where it releases a 140.5 keV gamma ray in approximately 89% of decays, transitioning to the ground state technetium-99. This emission is not a biological molecule, receptor, enzyme, or therapeutic target but a physical property exploited in nuclear medicine for diagnostic imaging. 99mTc, with a 6-hour half-life, is incorporated into radiopharmaceuticals that target organs or tissues, allowing gamma cameras to detect the emitted photons for visualizing structures like bones, heart, thyroid, kidneys, and tumors. It enables non-invasive detection of conditions such as cancer metastases, infections, cardiac dysfunction, and renal issues while minimizing patient radiation dose due to pure gamma emission and rapid decay. This process accounts for over 80-85% of nuclear medicine procedures worldwide, with no direct role in disease causation or drug targeting.

Other names

Tc-99m gamma ray emission99mTc 140 keV photon emission